Trial intelligence / Profile preview

Confirmatory study of BK-4SP in healthy infants

jRCT2080221090Phase 3

Sponsor
The Research Foundation for Microbial Diseases of Osaka University, Tanabe Pharma Corporation
Start
May 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3 trial of Tetrabik in Infectious disease, sponsored by The Research Foundation for Microbial Diseases of Osaka University, Tanabe Pharma Corporation.

02

Drugs

Tetrabik
03

Conditions

Infectious disease

Beyond the preview

Go deeper on jRCT2080221090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call